151 related articles for article (PubMed ID: 17216435)
21. Population Pharmacokinetics of Pyronaridine in Pediatric Malaria Patients.
Ayyoub A; Methaneethorn J; Ramharter M; Djimde AA; Tekete M; Duparc S; Borghini-Fuhrer I; Shin JS; Fleckenstein L
Antimicrob Agents Chemother; 2015 Dec; 60(3):1450-8. PubMed ID: 26666916
[TBL] [Abstract][Full Text] [Related]
22. Population pharmacokinetics of adefovir dipivoxil tablets in healthy Chinese volunteers.
Huang J; Zhang Y; Huang X; Li L; Li Y; Wang K; Yang J; He Y; Lv Y; Zheng Q
Int J Clin Pharmacol Ther; 2014 Jan; 52(1):8-14. PubMed ID: 24219967
[TBL] [Abstract][Full Text] [Related]
23. Population pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors.
Guo F; Letrent SP; Sharma A
Cancer Chemother Pharmacol; 2007 Nov; 60(6):799-809. PubMed ID: 17285315
[TBL] [Abstract][Full Text] [Related]
24. Mefloquine disposition in normals and in patients with severe Plasmodium falciparum malaria.
Juma FD; Ogeto JO
Eur J Drug Metab Pharmacokinet; 1989; 14(1):15-7. PubMed ID: 2668007
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of two paediatric artesunate mefloquine drug formulations in the treatment of uncomplicated falciparum malaria in Gabon.
Ramharter M; Kurth FM; Bélard S; Bouyou-Akotet MK; Mamfoumbi MM; Agnandji ST; Missinou MA; Adegnika AA; Issifou S; Cambon N; Heidecker JL; Kombila M; Kremsner PG
J Antimicrob Chemother; 2007 Nov; 60(5):1091-6. PubMed ID: 17884832
[TBL] [Abstract][Full Text] [Related]
26. A comparative study of gastrointestinal infections in United States soldiers receiving doxycycline or mefloquine for malaria prophylaxis.
Arthur JD; Echeverria P; Shanks GD; Karwacki J; Bodhidatta L; Brown JE
Am J Trop Med Hyg; 1990 Dec; 43(6):608-13. PubMed ID: 2267964
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of prophylactic mefloquine.
Karbwang J; Molunto P; Na Bangchang K; Banmairuroi V; Bunnag D; Harinasuta T
Southeast Asian J Trop Med Public Health; 1991 Dec; 22(4):519-22. PubMed ID: 1820637
[TBL] [Abstract][Full Text] [Related]
28. Comparative tolerability and kinetics during long-term intake of Lariam and Fansidar for malaria prophylaxis in nonimmune volunteers.
Rombo L; Angel VH; Friman G; Hellgren U; Mittelholzer ML; Stürchler D
Trop Med Parasitol; 1993 Sep; 44(3):254-6. PubMed ID: 8256106
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of prophylactic mefloquine in Thai healthy volunteers.
Karbwang J; Bangchang KN; Supapojana A; Bunnag D; Harinasuta T
Southeast Asian J Trop Med Public Health; 1991 Mar; 22(1):68-71. PubMed ID: 1948262
[TBL] [Abstract][Full Text] [Related]
30. Artesunate with mefloquine at various intervals for non-severe Plasmodium falciparum malaria.
Hung le Q; de Vries PJ; Binh TQ; Giao PT; Nam NV; Holman R; Kager PA
Am J Trop Med Hyg; 2004 Aug; 71(2):160-6. PubMed ID: 15306704
[TBL] [Abstract][Full Text] [Related]
31. Comparison of mefloquine, chloroquine plus pyrimethamine-sulfadoxine (Fansidar), and chloroquine as malarial prophylaxis in eastern Thailand.
Boudreau EF; Pang LW; Chaikummao S; Witayarut C
Southeast Asian J Trop Med Public Health; 1991 Jun; 22(2):183-9. PubMed ID: 1948277
[TBL] [Abstract][Full Text] [Related]
32. Population pharmacokinetics of APOMINE: a meta-analysis in cancer patients and healthy males.
Bonate PL; Floret S; Bentzen C
Br J Clin Pharmacol; 2004 Aug; 58(2):142-55. PubMed ID: 15255796
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic evaluation of the vinorelbine-lapatinib combination in the treatment of breast cancer patients.
Rezai K; Urien S; Isambert N; Roche H; Dieras V; Berille J; Bonneterre J; Brain E; Lokiec F
Cancer Chemother Pharmacol; 2011 Dec; 68(6):1529-36. PubMed ID: 21519841
[TBL] [Abstract][Full Text] [Related]
34. Mefloquine and doxycycline malaria prophylaxis in Australian soldiers in East Timor.
Kitchener SJ; Nasveld PE; Gregory RM; Edstein MD
Med J Aust; 2005 Feb; 182(4):168-71. PubMed ID: 15720172
[TBL] [Abstract][Full Text] [Related]
35. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.
Overbosch D; Schilthuis H; Bienzle U; Behrens RH; Kain KC; Clarke PD; Toovey S; Knobloch J; Nothdurft HD; Shaw D; Roskell NS; Chulay JD;
Clin Infect Dis; 2001 Oct; 33(7):1015-21. PubMed ID: 11528574
[TBL] [Abstract][Full Text] [Related]
36. Development of a physiologically based pharmacokinetic model for mefloquine and its application alongside a clinical effectiveness model to select an optimal dose for prevention of malaria in young Caucasian children.
Johnson TN; Cleary Y; Parrott N; Reigner B; Smith JR; Toovey S
Br J Clin Pharmacol; 2019 Jan; 85(1):100-113. PubMed ID: 30198595
[TBL] [Abstract][Full Text] [Related]
37. Population pharmacokinetic investigation of low-dose methotrexate in rheumatoid arthritics Japanese patients.
Yukawa E; Mori S; Ueda K; Nakada Y
J Clin Pharm Ther; 2007 Dec; 32(6):573-8. PubMed ID: 18021334
[TBL] [Abstract][Full Text] [Related]
38. Mefloquine versus doxycycline for malaria prophylaxis in intermittent exposure of Israeli Air Force aircrew in Rwanda.
Shamiss A; Atar E; Zohar L; Cain Y
Aviat Space Environ Med; 1996 Sep; 67(9):872-3. PubMed ID: 9025805
[TBL] [Abstract][Full Text] [Related]
39. Population pharmacokinetics of primaquine and the effect of hepatic and renal dysfunction: An exploratory approach.
Sridharan K; Sannala CKR; Mallayasamy S; Chaturvedula A; Kadam P; Hase N; Shukla A; Gogtay N; Thatte U
Indian J Pharmacol; 2019; 51(1):17-24. PubMed ID: 31031463
[TBL] [Abstract][Full Text] [Related]
40. Steady state pharmacokinetics of mefloquine in long-term travellers.
Pennie RA; Koren G; Crevoisier C
Trans R Soc Trop Med Hyg; 1993; 87(4):459-62. PubMed ID: 8249080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
